Filtered By:
Specialty: Cancer & Oncology
Source: EurekAlert! - Cancer
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 59 results found since Jan 2013.
Most nations falling short of UN targets to cut premature deaths from chronic diseases
(Imperial College London) People in the UK, US and China have a higher risk of dying early from conditions like cancer, heart disease and stroke than people in Italy, France, South Korea and Australia.
Source: EurekAlert! - Cancer - September 20, 2018 Category: Cancer & Oncology Source Type: news
AFib patients with cancer history less likely to see cardiologist, fill prescriptions
(American College of Cardiology) Atrial fibrillation (AFib) patients with a history of cancer are less likely to see a cardiologist or fill anticoagulant prescriptions compared with AFib patients who never had cancer, according to a study in the Journal of the American College of Cardiology. By not filling and taking prescribed medication, these patients are potentially putting themselves at increased risk of stroke.
Source: EurekAlert! - Cancer - October 8, 2018 Category: Cancer & Oncology Source Type: news
VITAL study: How vitamin D and fish oil affect risk of heart attack, stroke and cancer
(Brigham and Women's Hospital) Brigham and Women's Hospital investigators leading the VITamin D and OmegA-3 TriaL (VITAL) conducted a rigorous placebo-controlled trial over the course of 5.3 years, gleaning a treasure trove of information on the effects of both supplements.
Source: EurekAlert! - Cancer - November 10, 2018 Category: Cancer & Oncology Source Type: news
Platelet 'decoys' outsmart both clots and cancer
(Wyss Institute for Biologically Inspired Engineering at Harvard) What do heart disease, stroke, sepsis, and cancer have in common, aside from being deadly diseases? They're all linked to platelets, the cells in our blood that normally help our blood clot. New research from the Wyss Institute has created 'decoy' platelets that can both prevent blood clots and keep cancer from spreading.
Source: EurekAlert! - Cancer - February 13, 2019 Category: Cancer & Oncology Source Type: news
Study unveils a blueprint for treating a deadly brain tumor
(NIH/National Institute of Neurological Disorders and Stroke) In a study of mice and human brain tumors researchers at the University of the Michigan, Ann Arbor, searched for new treatments by exploring the reasons why some patients with gliomas live remarkably longer than others. The results suggested that certain patients' tumor cells are less aggressive and much better at repairing DNA than others but are difficult to kill with radiation. The researchers then showed that combining radiation therapy with cancer drugs designed to block DNA repair may be an effective treatment strategy.
Source: EurekAlert! - Cancer - February 19, 2019 Category: Cancer & Oncology Source Type: news
Jawless fish take a bite out of the blood-brain barrier
(University of Wisconsin-Madison) A jawless parasitic fish could help lead the way to more effective treatments for multiple brain ailments, including cancer, trauma and stroke. A team of biomedical engineers and clinician-scientists at the University of Wisconsin-Madison and the University of Texas at Austin borrowed molecules from the immune system of the parasitic sea lamprey to deliver anti-cancer drugs directly to brain tumors.
Source: EurekAlert! - Cancer - May 15, 2019 Category: Cancer & Oncology Source Type: news
Omega-3 fats do not protect against cancer
(University of East Anglia) Omega-3 fats do not protect against cancer -- according to new University of East Anglia research. Increased consumption of omega-3 fats is widely promoted globally because of a common belief that it will protect against, or even reverse, diseases such as cancer, heart attacks and stroke. But two systematic reviews find that omega-3 supplements may slightly reduce coronary heart disease mortality and events, but slightly increase risk of prostate cancer. Both beneficial and harmful effects are small.
Source: EurekAlert! - Cancer - February 28, 2020 Category: Cancer & Oncology Source Type: news
Diagnosis to therapy: The future of image-guided patient management
(Society of Nuclear Medicine and Molecular Imaging) SNMMI's Virtual Annual Meeting will convene more than 6,000 attendees from around the globe to share novel research on new and better ways to diagnose and treat cancers, inflammation, arthritis, chronic pain, stroke, brain disease, and more.The focus is on precision medicine--improving patients' lives by developing new ways to diagnose earlier and more accurately, delivering the most effective therapy for a specific patient's disease, and monitoring and adjusting treatment to ensure optimum results.
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news
Drugs against alpha-ketoglutarate may combat deadly childhood brain tumor
(NIH/National Institute of Neurological Disorders and Stroke) Every year, 150 to 300 children in the United States are diagnosed with diffuse intrinsic pontine gliomas (DIPGs), aggressive and lethal tumors that grow deep inside the brain, for which there are no cures. In a study funded by the National Institutes of Health, researchers showed that experimental drugs designed to lower the body's natural production of alpha-ketoglutarate extended the lives of mice harboring DIPG tumors by slowing the growth of the cancer cells.
Source: EurekAlert! - Cancer - August 18, 2020 Category: Cancer & Oncology Source Type: news
Making sense of diabetes
(University of Missouri-Columbia) Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units. She noticed diabetes is rarely referred to as a primary cause of death in itself, yet the disease is a leading contributor to deaths involving heart disease, stroke and cancer.
Source: EurekAlert! - Cancer - September 21, 2020 Category: Cancer & Oncology Source Type: news
Continuous monitoring of proteins a game-changer for patients with deteriorating health
(Monash University) A world-first discovery by Australian researchers could become a game-changer for patients at risk of rapid health deterioration, such as heart complications, stroke, sepsis and cancer. Researchers developed an antibody as a biosensor, to continuously monitor rapid changes in the concentration of EGFR, a protein present on cancer cells and in body fluids.
Source: EurekAlert! - Cancer - January 25, 2021 Category: Cancer & Oncology Source Type: news
Combination treatment for common glioma type shows promise in mice
(NIH/National Institute of Neurological Disorders and Stroke) Gliomas are common brain tumors that comprise about one third of all cancers of the nervous system. In a study funded by the National Institutes of Health (NIH), researchers tested a novel combination treatment approach on mice with tumors with characteristics similar to human astrocytomas and found tumor regression in 60 percent of the mice treated. These encouraging results could be the first step toward developing a treatment for this type of brain cancer.
Source: EurekAlert! - Cancer - February 16, 2021 Category: Cancer & Oncology Source Type: news
First of its kind study links wildfire smoke to skin disease
(University of California - San Francisco) Wildfire smoke can trigger a host of respiratory and cardiovascular symptoms, ranging from runny nose and cough to a potentially life-threatening heart attack or stroke. A new study suggests that the dangers posed by wildfire smoke may also extend to the largest organ in the human body, and our first line of defense against outside threat: the skin.
Source: EurekAlert! - Cancer - April 21, 2021 Category: Cancer & Oncology Source Type: news
Optic nerve firing may spark growth of vision-threatening childhood tumor
(NIH/National Institute of Neurological Disorders and Stroke) In a study of mice, researchers showed how the act of seeing light may trigger the formation of vision-harming tumors in young children who are born with neurofibromatosis type 1 (NF1) cancer predisposition syndrome. The research team, funded by the National Institutes of Health, focused on tumors that grow within the optic nerve, which relays visual signals from the eyes to brain. They discovered that the neural activity which underlies these signals can both ignite and feed the tumors.
Source: EurekAlert! - Cancer - June 1, 2021 Category: Cancer & Oncology Source Type: news
